Position in REGN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$7,181,310
-$1,575,790 QoQ
Shares Held
11,517
+1.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#340
of 1,322 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avanza Fonder AB holds $21,519,303 across 6 Biotechnology names. REGN ranks #2 (33.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
28,198 | $14,006,791 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
11,517 | $7,181,310 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
399 | $120,110 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,649 | $92,458 | |
| 5 | INCY |
Incyte Corp
|
628 | $71,189 | |
| 6 | INSM |
INSMED Inc
|
445 | $47,445 |
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,181,310 | 11,517 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $8,757,100 | 11,334 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $9,406,779 | 12,187 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $5,958,375 | 10,597 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $5,111,925 | 9,737 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $5,644,012 | 8,899 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $7,413,930 | 10,408 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||